Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis

Biomedicines
Jorge CorrealeMaría Célica Ysrraelit

Abstract

Multiple Sclerosis (MS) is a major cause of neurological disability, which increases predominantly during disease progression as a result of cortical and grey matter structures involvement. The gradual accumulation of disability characteristic of the disease seems to also result from a different set of mechanisms, including in particular immune reactions confined to the Central Nervous System such as: (a) B-cell dysregulation, (b) CD8⁺ T cells causing demyelination or axonal/neuronal damage, and (c) microglial cell activation associated with neuritic transection found in cortical demyelinating lesions. Other potential drivers of neurodegeneration are generation of oxygen and nitrogen reactive species, and mitochondrial damage, inducing impaired energy production, and intra-axonal accumulation of Ca2+, which in turn activates a variety of catabolic enzymes ultimately leading to progressive proteolytic degradation of cytoskeleton proteins. Loss of axon energy provided by oligodendrocytes determines further axonal degeneration and neuronal loss. Clearly, these different mechanisms are not mutually exclusive and could act in combination. Given the multifactorial pathophysiology of progressive MS, many potential therapeutic targets ...Continue Reading

References

Dec 5, 1981·Lancet·H B Warner, R I Carp
May 1, 1996·The Journal of Clinical Investigation·D SchmidtC M Weyand
Mar 1, 1997·Brain : a Journal of Neurology·B FergusonV H Perry
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·C MatuteR Miledi
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Apr 4, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·J N LyckeL E Rosengren
Aug 3, 1999·Journal of Neuroimmunology·S J Lee, E N Benveniste
Mar 16, 2000·Trends in Neurosciences·H D VentersK W Kelley
May 29, 2000·Brain : a Journal of Neurology·A BitschW Brück
Oct 12, 2001·Glia·Y Dong, E N Benveniste
Jan 5, 2002·JAMA : the Journal of the American Medical Association·A AscherioD J Hunter
Mar 2, 2002·Brain : a Journal of Neurology·Marc JacobsenBernhard Hemmer
Apr 12, 2002·Nature·Elizabeth J BradburyStephen B McMahon
Apr 12, 2002·Glia·Larry S ShermanCharles Kuntz
Sep 24, 2002·Brain : a Journal of Neurology·Tanja KuhlmannWolfgang Brück
Feb 19, 2003·Nature Genetics·Corinna Lappe-SiefkeKlaus-Armin Nave
Jun 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabrizio GiulianiV Wee Yong
Aug 7, 2003·Journal of Neuropathology and Experimental Neurology·Lars BøSverre J Mørk
Aug 21, 2003·Multiple Sclerosis : Clinical and Laboratory Research·L BøS J Mørk
Oct 3, 2003·Nature Reviews. Immunology·Ralf Küppers
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Christian SkulinaNorbert Goebels
Mar 30, 2004·Annals of Neurology·Michael H Barnett, John W Prineas
May 18, 2004·Journal of Neuroimmunology·Mary Ann T GimenezJohn H Russell
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Matthew J CranerStephen G Waxman
Jun 10, 2004·Neurochemistry International·Angus M BrownBruce R Ransom
May 19, 2005·Journal of the Neurological Sciences·Peter K Stys
Aug 10, 2005·Journal of Neuroimmunology·Merja Soilu-HänninenMartin Panelius
Oct 19, 2005·Brain : a Journal of Neurology·Alexandra KutzelniggHans Lassmann

❮ Previous
Next ❯

Citations

Jan 15, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·I V SmaginaL P Galaktionova
Jan 31, 2020·Journal of Neuroinflammation·Nickoleta DelivanoglouConstantina Simeonidou
Apr 21, 2020·Expert Review of Neurotherapeutics·Eleonora TavazziNiels Bergsland
May 7, 2020·Neurodegenerative Disease Management·Galina VorobeychikAshley Cox
Sep 10, 2020·Frontiers in Immunology·L CleenewerkAstrid Hogenkamp
Jun 21, 2020·International Journal of Molecular Sciences·Madeline BrossEvanthia Bernitsas
Jan 14, 2021·International Journal of Biological Macromolecules·Marjan TalebiSaeed Samarghandian
Mar 26, 2021·Frontiers in Aging Neuroscience·Biyao WangXinwen Zhang
Apr 10, 2021·Current Neurology and Neuroscience Reports·Tyrell J SimkinsDennis Bourdette
May 13, 2021·Annals of Clinical and Translational Neurology·Ajai TripathiRanjan Dutta
Jun 15, 2021·Expert Opinion on Investigational Drugs·Rujapope SutiwisesakArthur E Warrington
Jul 25, 2021·International Journal of Molecular Sciences·Monokesh K SenJens R Coorssen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.